If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 737.00
Bid: 738.00
Ask: 743.00
Change: -12.00 (-1.60%)
Spread: 5.00 (0.678%)
Open: 718.00
High: 750.00
Low: 718.00
Prev. Close: 749.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

29 Jul 2014 14:14

RNS Number : 6390N
Acal PLC
29 July 2014
 



 

 

 

29 July 2014

 

Acal plc

 

Results of Annual General Meeting

 

 

Acal plc (LSE: ACL, "Acal" or "The Group"), a leading international electronics specialist, announces that, at the Annual General Meeting held earlier today, all resolutions were carried on a show of hands. The following levels of proxy votes were received.

 

Resolution

For

Against

Chairman's Discretion

Withheld

1

Receipt and Adoption of

Financial Statements

38,639,649

0

37,803

501,846

2

Approval of Final Dividend

38,640,347

1,148

37,803

500,000

3

Approval of Directors'

Remuneration Report

38,635,649

503,846

37,803

2,000

4

Approval of Directors'

Remuneration Policy

36,825,649

2,313,846

37,803

2,000

5

Re-election of S Gibbins

38,641,437

58

37,803

500,000

6

Re-election of R J Moon

36,831,437

2,310,058

37,803

0

7

Re-election of G J Williams

38,641,437

500,058

37,803

0

8

Re-appointment of Auditors

38,641,495

0

37,803

500,000

9

Authority to fix Auditors' Remuneration

38,641,495

0

37,803

500,000

10

Authority to Allot Shares

38,639,649

1,846

37,803

500,000

11

Additional Authority to Allot Shares

(rights issue)

38,638,613

2,882

37,803

500,000

12

Authority to Disapply Statutory

Pre-Emption Rights

38,633,308

3,305

37,803

504,882

13

Authority to Disapply Statutory

Pre-Emption Rights (rights issue)

38,638,190

3,305

37,803

500,000

14

Authority to Purchase Company's Own Shares

38,634,842

6,653

37,803

500,000

15

Notice of General Meetings

38,640,289

1,206

37,803

500,000

16

Approval of Acal plc 2014 Unapproved Share Option Plan

38,633,570

504,527

37,803

3,398

 

As at today's date Acal plc has 63,049,220 ordinary shares in issue.

 

A copy of the resolutions approved by Shareholders will be placed on the National Storage Mechanism.

 

 

G P Shillinglaw

Group Company Secretary

Tel: 01483 544500

 

 

 

 

 

For further information please contact:

 

Acal plc

Nick Jefferies - Group Chief Executive 01483 544500

Simon Gibbins - Group Finance Director

Gary Shillinglaw - Group Company Secretary

 

Instinctif Partners

Mark Garraway 020 7457 2020

Helen Tarbet

 

 

 

 

 

 

 

 

 

 

Notes to Editors:

 

About Acal plc

 

 

 

Acal is a European leader in specialist electronics, designing, manufacturing and distributing electronic, photonic and medical products for the industrial and healthcare sectors. It is the only such provider with an infrastructure to deliver a broad range of specialist products and bespoke solutions across Europe. Acal's strategy is to further enhance its leadership position through organic growth, complementary acquisitions and continued enhancement of its custom service capabilities. It has completed eight acquisitions in the last four years, increasing its specialist revenue more than four-fold. Acal has operating companies across Europe, including the UK, Germany, France, Benelux, Italy, Poland, Spain and the Nordic region, as well as in Asia (China, India, Sri Lanka and South Korea), the US and South Africa. Businesses comprise Acal BFi, Hectronic, MTC, Myrra Group, Noratel, RSG, Stortech and Vertec.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGUKAORSAABUAR
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.